A Phase 1 Dose Escalation Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
A Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Males aged 18 years or older at time of informed consent.
• Have a histologically confirmed diagnosis of prostate cancer, and are scheduled to undergo radical prostatectomy within 28 days of screening.
• Grade Group 2-5.
• Eastern Cooperative Oncology Group (ECOG) Performance Status ≤2 at Screening.
• Have adequate organ and bone marrow function at screening.
• Able to understand and be willing to sign an Institutional Review Board/Ethics Committee-approved written informed consent document
Locations
United States
Arizona
Arizona Urology Specialists
RECRUITING
Tucson
Florida
University of Florida
RECRUITING
Gainesville
Other Locations
Australia
Australian Prostate Center
RECRUITING
Melbourne N.
Epworth HealthCare
RECRUITING
Melbourne N.
Contact Information
Primary
Kayti Aviano
kayti@surgetx.com
781-605-8632
Time Frame
Start Date: 2025-05-08
Estimated Completion Date: 2026-03
Participants
Target number of participants: 18
Treatments
Experimental: STM-416p
STM-416p
Related Therapeutic Areas
Sponsors
Leads: SURGE Therapeutics